Skip to main content

Table 5 WOMAC scores and changes—participants with WOMAC pain scorea ≥ 8 at T0

From: Exploring determinants predicting response to intra-articular hyaluronic acid treatment in symptomatic knee osteoarthritis: 9-year follow-up data from the Osteoarthritis Initiative

 

Total

High,b WOMAC paina ≥ 8

  

Responders and nonresponders (n = 112)c

Respondersd (n = 63)

Nonresponderse (n = 49)

p valuef

p valueg

WOMAC at T0

 

(n = 112)

(n = 63)

(n = 49)

  

 Pain (0–20)

10.44 ± 2.28

10.87 ± 2.37

9.88 ± 2.05

0.008

0.112

 

(n = 104)

(n = 62)

(n = 42)

  

 Function (0–68)

29.93 ± 9.43

30.95 ± 8.93

28.41 ± 10.04

0.229

0.223

 

(n = 112)

(n = 63)

(n = 49)

  

 Stiffness (0–8)

3.85 ± 1.50

3.87 ± 1.40

3.82 ± 1.64

0.966

0.364

 

(n = 104)

(n = 62)

(n = 42)

  

 Total (0–96)

44.24 ± 11.67

45.63 ± 11.07

42.20 ± 12.36

0.146

0.163

WOMAC change (T0 to T1)

 

(n = 112)

(n = 63)

(n = 49)

  

 Pain

−2.41 ± 4.06

−5.31 ± 2.84

1.33 ± 1.52

< 0.001

< 0.001

  20% ≤ decrease < 40%

 

59% (37)

   

  Decrease > 40%

 

41% (26)

   
 

(n = 104)

(n = 62)

(n = 42)

  

 Function

−5.30 ± 14.52

−11.88 ± 10.99

4.42 ± 13.69

< 0.001

< 0.001

  20% ≤ decrease < 40%

 

44% (27)

   

  Decrease > 40%

 

21% (13)

   
 

(n = 112)

(n = 63)

(n = 49)

  

 Stiffness

−0.16 ± 2.16

−0.75 ± 2.03

0.59 ± 2.10

< 0.010

< 0.001

  20% ≤ decrease < 40%

 

30% (19)

   

  Decrease > 40%

 

25% (16)

   
 

(n = 104)

(n = 62)

(n = 42)

  

 Total

−8.17 ± 18.97

−17.95 ± 14.13

6.27 ± 15.76

< 0.001

< 0.001

  20% ≤ decrease < 40%

 

44% (27)

   

  Decrease > 40%

 

27% (17)

  1. Results are shown as mean ± standard deviation or % and number (n) of participants’ IAHA injected knees. Bold data are significant at p < 0.05
  2. T0 visit before IAHA treatment, TI visit after IAHA treatment, IAHA intra-articular hyaluronic acid, WOMAC Western Ontario and McMaster Universities Osteoarthritis Index
  3. aThe level of pain on WOMAC score was divided into three groups (Low, Moderate, and High) based on tertile analysis: High represents patients in the highest tertile
  4. bWOMAC Likert 3.1 (scale 0–20) pain scores at T0
  5. cNumber of injected knees based on 99 participants
  6. dResponders had a decrease in WOMAC pain score of at least 20% between T0 and T1
  7. eNonresponders had the same WOMAC pain score or an increase in WOMAC pain score between T0 and T1
  8. fContinuous variables were compared using Student’s t test/Mann–Whitney test
  9. gContinuous variables were analyzed using a linear mixed model adjusted for age, sex, and body mass index